The Effects of Fibrinogen Concentrate Infusion on Blood Loss and Allogeneic Blood Conservation in Scoliosis Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

June 14, 2017

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Scoliosis; AdolescenceBleedingSurgery
Interventions
DRUG

Fibrinogen Concentrate Human

After start of surgery when all pedicle screws are placed, the patients in treatment group will receive fibrinogen concentrate 30mg kg-1. For safety concern, functional fibrinogen will be measured and the maximum fibrinogen concentrate administration for each individual shall not exceed 2g. Fibrinogen concentrate will be diluted in 100mL of sterile water and then be administered to patients.

DRUG

Normal saline

100mL normal saline will be administered to patients in control group as placebo

Trial Locations (1)

100730

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER

NCT03183479 - The Effects of Fibrinogen Concentrate Infusion on Blood Loss and Allogeneic Blood Conservation in Scoliosis Surgery | Biotech Hunter | Biotech Hunter